Cytotoxic Activity of A New Isoform l-Amino Acid Oxidase (Balt-LAAO-II) From Bothrops alternatus (Urutu) Snake Venom in Human Leukemic HL60 Cells-Reference-Cited by-同舟云学术

Cytotoxic Activity of A New Isoform l-Amino Acid Oxidase (Balt-LAAO-II) From Bothrops alternatus (Urutu) Snake Venom in Human Leukemic HL60 Cells

Published:2023-11-22 Issue:1 Volume:30 Page:
ISSN:1573-3904
Container-title:International Journal of Peptide Research and Therapeutics
language:en
Short-container-title:Int J Pept Res Ther

Author:

Heleno Mauricio Aurelio Gomes,Nowill Alexandre,de Carvalho João Ernesto,Suni-Curasi Diego L.,Vilca-Quispe Julissa,Ponce-Fuentes Emilio Alberto,Obando-Pereda Gustavo Alberto,Ponce-Soto Luis Alberto

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Molecular Medicine,Biochemistry,Bioengineering,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s10989-023-10574-7.pdf

Reference48 articles.

1. Abdelkafi-Koubaa Z, ELBini-Dhouib I, Souid S, Jebali J, Doghri R, Srairi-Abid N, Essafi-Benkhadir K, Micheau O, Marrakchi N (2021) Pharmacological investigation of cc-laao, an l-amino acid oxidase from Cerastes cerastes snake venom. Toxins 13(12):904

2. Bonfim V, De Carvalho D, Ponce-Soto L, Kassab B, Marangoni S (2009) Toxicity of phospholipases a 2 d49 (6–1 and 6–2) and k49 (bj-vii) from Bothrops jararacussu venom. Cell Biol Toxicol 25:523–532

3. Borkow G, Gutiérrez J, Ovadia M (1995) In vitro activity of bah1, the main hemorrhagic toxin of Bothrops asper snake venom on bovine endothelial cells. Toxicon 33(10):1387–1391

4. Burin SM, Cacemiro MdC, Cominal JG, Grandis RAD, Machado ART, Donaires FS, Cintra ACO, Ambrosio L, Antunes LMG, Sampaio SV, et al (2020) Bothrops moojeni l-amino acid oxidase induces apoptosis and epigenetic modulation on bcr-abl+ cells. Journal of Venomous Animals and Toxins including Tropical Diseases 26

5. Cesar PH, Braga MA, Trento MVC, Menaldo DL, Marcussi S (2019) Snake venom disintegrins: an overview of their interaction with integrins. Curr Drug Targets 20(4):465–477